Synergetics found guilty in patent battle

Article

Iridex has been granted a summary judgement, by the US District Court for the Eastern District of Missouri, on its against Synergetics.

Iridex has been granted a summary judgement, by the US District Court for the Eastern District of Missouri, on its claim that Synergetics' adapter-based connector systems infringe 12 separate claims of Iridex's Patent No. 5,085,492.

A jury trial is now scheduled for April 2007, during which time the jury will be asked to award damages and decide whether Synergetics' infringement was wilful, if so the damages will be increased. Iridex now feels that its requests for triple damages and an injunction are now more likely to be granted.

Two summary judgement motions remain for the Court to decide.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.